Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccinationDaniel E Speiser, Petra Baumgaertner, Catherine Barbey, et al.Investigative Ophthalmology & Visual Science|June 28, 2019
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways InhibitionIkram El Zaoui, Maya Bucher, Donata Rimoldi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvantDanielle Lienard, Marie-Françoise Avril, Frédérique-Anne Le Gal, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor siteVictor Appay, Camilla Jandus, Verena Voelter, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivityDanila Valmori, Valerie Dutoit, Valerie Schnuriger, et al.Plos Genetics|December 31, 2020
Genomic and transcriptomic landscape of conjunctival melanomaKatarina Cisarova, Marc Folcher, Ikram El Zaoui, et al.Plos One|February 21, 2012
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localizationLukas Baitsch, Amandine Legat, Leticia Barba, et al.Cancer Research|February 24, 2011
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancerBruno Salaun, Laurence Zitvogel, Carine Asselin-Paturel, et al.Cancer Research|April 17, 2004
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional toleranceAlfred Zippelius, Pascal Batard, Verena Rubio-Godoy, et al.Cancer Research|March 26, 2002
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activityDanila Valmori, Carmen Scheibenbogen, Valerie Dutoit, et al.Pageof 7